The correlation analysis highlighted that the expression of Cer (18:1/18:0) was strongly positively correlated with PASI not only in an early stage of PV such as SP group but also in all enrolled patients with PV, which can be considered a severity biomarker for clinical reference. This evidence concerns the gene CBLN1 and acquired polycythemia vera.